AxoGen Price to Book Ratio 2010-2024 | AXGN
Historical price to book ratio values for AxoGen (AXGN) over the last 10 years. The current price to book ratio for AxoGen as of December 25, 2024 is 6.90.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AxoGen Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-12-24 | 16.26 | 7.20 | |
| 2024-09-30 | 14.02 | $2.26 | 6.21 |
| 2024-06-30 | 7.24 | $2.18 | 3.32 |
| 2024-03-31 | 8.07 | $2.13 | 3.78 |
| 2023-12-31 | 6.83 | $2.22 | 3.08 |
| 2023-09-30 | 5.00 | $2.27 | 2.20 |
| 2023-06-30 | 9.13 | $2.26 | 4.04 |
| 2023-03-31 | 9.45 | $2.28 | 4.15 |
| 2022-12-31 | 9.98 | $2.38 | 4.19 |
| 2022-09-30 | 11.92 | $2.40 | 4.97 |
| 2022-06-30 | 8.19 | $2.41 | 3.39 |
| 2022-03-31 | 7.94 | $2.47 | 3.21 |
| 2021-12-31 | 9.37 | $2.70 | 3.47 |
| 2021-09-30 | 15.80 | $2.77 | 5.70 |
| 2021-06-30 | 21.61 | $2.87 | 7.53 |
| 2021-03-31 | 20.26 | $2.93 | 6.91 |
| 2020-12-31 | 17.90 | $3.03 | 5.90 |
| 2020-09-30 | 11.63 | $3.03 | 3.83 |
| 2020-06-30 | 9.24 | $2.99 | 3.09 |
| 2020-03-31 | 10.40 | $3.13 | 3.33 |
| 2019-12-31 | 17.89 | $3.34 | 5.36 |
| 2019-09-30 | 12.48 | $3.43 | 3.64 |
| 2019-06-30 | 19.80 | $3.51 | 5.63 |
| 2019-03-31 | 21.06 | $3.60 | 5.86 |
| 2018-12-31 | 20.43 | $3.78 | 5.41 |
| 2018-09-30 | 36.85 | $3.87 | 9.53 |
| 2018-06-30 | 50.25 | $3.93 | 12.79 |
| 2018-03-31 | 36.50 | $0.63 | 58.33 |
| 2017-12-31 | 28.30 | $0.73 | 38.60 |
| 2017-09-30 | 19.35 | $0.32 | 61.23 |
| 2017-06-30 | 16.75 | $0.34 | 49.15 |
| 2017-03-31 | 10.45 | $0.37 | 28.50 |
| 2016-12-31 | 9.00 | $0.45 | 19.91 |
| 2016-09-30 | 9.03 | $0.04 | 247.40 |
| 2016-06-30 | 6.88 | $0.09 | 74.22 |
| 2016-03-31 | 5.36 | $0.16 | 33.27 |
| 2015-12-31 | 5.00 | $0.27 | 18.29 |
| 2015-09-30 | 4.12 | $0.37 | 11.00 |
| 2015-06-30 | 3.14 | $-0.14 | -22.18 |
| 2015-03-31 | 3.50 | $-0.03 | -128.21 |
| 2014-12-31 | 3.59 | $-0.58 | -6.22 |
| 2014-09-30 | 2.44 | $-0.58 | -4.18 |
| 2014-06-30 | 2.78 | $-0.41 | -6.77 |
| 2014-03-31 | 3.05 | $-0.21 | -14.41 |
| 2013-12-31 | 4.49 | $0.01 | 568.35 |
| 2013-09-30 | 4.44 | $0.24 | 18.71 |
| 2013-06-30 | 4.34 | $-0.83 | -5.20 |
| 2013-03-31 | 3.61 | $-0.54 | -6.69 |
| 2012-12-31 | 2.70 | $-0.25 | -10.61 |
| 2012-09-30 | 2.70 | $0.11 | 24.88 |
| 2012-06-30 | 3.00 | $0.29 | 10.19 |
| 2012-03-31 | 2.70 | $0.37 | 7.25 |
| 2011-12-31 | 2.70 | $0.55 | 4.92 |
| 2011-09-30 | 2.50 | $0.73 | 3.44 |
| 2011-06-30 | 3.00 | $2.68 | 1.12 |
| 2011-03-31 | 2.75 | $2.59 | 1.06 |
| 2010-12-31 | 3.49 | $-9.70 | -0.36 |
| 2010-09-30 | 3.50 | $2.38 | 1.47 |
| 2010-06-30 | 2.99 | $2.47 | 1.21 |
| 2010-03-31 | 3.10 | $2.52 | 1.23 |
| 2009-12-31 | 3.29 | $2.58 | 1.28 |
| 2009-09-30 | 3.64 | $0.04 | 83.70 |
| 2009-06-30 | 2.86 | $0.07 | 38.65 |
| 2009-03-31 | 3.89 | $0.04 | 93.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.688B | $0.159B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.142B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |